STAR Market_Providing professional financial news and data related to STAR Market, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Duality Biotherapeutics (09606.HK) ：Passes Shanghai CSRC Bureau IPO Tutoring Inspection for STAR Market Listing

Tags：

Duality Biotherapeutics 09606.HK STAR Market

2026-06-10

STAR Market to see the largest planned fundraising in history? Bosera STAR 50 Index ETF (02832.HK) rises over 3%, attracting much market attention

Tags：

Bosera STAR 50 Index ETF 02832.HK STAR Market

2026-01-12

Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea
Finance
Overseas Chinese Town Asia (03366.HK): 100% Equity Interest in Huizhou Project Put Up for Public Listing Sale, Winning Bid Price at Approximately RMB 307 Million
Finance
Sino Biopharmaceutical (01177.HK): TRD205 (AT2R Antagonist) Included in CDE’s Breakthrough Therapy Designation List
Finance
Weigao Group(01066.HK): Controlling Shareholder Adds Approximately 15.5988 Million H Shares, Cumulative Share Purchase Hits Around 30.55 Million Shares

Scan QR Code

Download App